Goethe University Frankfurt-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2016

  1. Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): A randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICOENGOT- GCIG intergroup study (HECTOR)

    Annals of Oncology, Vol. 27, Núm. 12, pp. 2236-2241